Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia; Australasian Kidney Trials Network, School of Medicine, University of Queensland, Brisbane, Australia.
Sydney School of Public Health, University of Sydney, Sydney, Australia; Centre for Kidney Research, The Children's Hospital at Westmead, Westmead, Sydney, Australia.
Am J Kidney Dis. 2018 May;71(5):690-700. doi: 10.1053/j.ajkd.2017.12.003. Epub 2018 Feb 23.
Vascular access outcomes in hemodialysis are critically important for patients and clinicians, but frequently are neither patient relevant nor measured consistently in randomized trials. A Standardized Outcomes in Nephrology-Hemodialysis (SONG-HD) consensus workshop was convened to discuss the development of a core outcome measure for vascular access. 13 patients/caregivers and 46 professionals (clinicians, policy makers, industry representatives, and researchers) attended. Participants advocated for vascular access function to be a core outcome based on the broad applicability of function regardless of access type, involvement of a multidisciplinary team in achieving a functioning access, and the impact of access function on quality of life, survival, and other access-related outcomes. A core outcome measure for vascular access required demonstrable feasibility for implementation across different clinical and trial settings. Participants advocated for a practical and flexible outcome measure with a simple actionable definition. Integrating patients' values and preferences was warranted to enhance the relevance of the measure. Proposed outcome measures for function included "uninterrupted use of the access without the need for interventions" and "ability to receive prescribed dialysis," but not "access blood flow," which was deemed too expensive and unreliable. These recommendations will inform the definition and implementation of a core outcome measure for vascular access function in hemodialysis trials.
血管通路结局在血液透析中对患者和临床医生至关重要,但在随机试验中通常既与患者无关,也不一致地进行测量。召开了标准化肾脏病-血液透析结局(SONG-HD)共识研讨会,以讨论血管通路核心结局测量的制定。13 名患者/护理人员和 46 名专业人员(临床医生、政策制定者、行业代表和研究人员)参加了会议。与会者主张根据功能的广泛适用性(无论通路类型如何)、多学科团队在实现功能通路方面的参与,以及功能通路对生活质量、生存和其他与通路相关的结局的影响,将血管通路功能作为核心结局。血管通路的核心结局测量需要在不同的临床和试验环境中具有可证明的实施可行性。与会者主张采用实用且灵活的、具有简单可操作定义的结局测量方法。需要整合患者的价值观和偏好,以增强测量的相关性。提出的功能结局测量方法包括“无需干预即可不间断地使用通路”和“能够接受规定的透析”,但不包括“通路血流量”,因为它被认为太昂贵且不可靠。这些建议将为血液透析试验中血管通路功能的核心结局测量的定义和实施提供信息。